Clemens Grassberger, PhD, on NSCLC: Therapy Sequencing Criteria

Posted: Wednesday, October 4, 2017

Clemens Grassberger, PhD, of Harvard Medical School, discusses tumor-specific modeling of chemotherapy combined with radiation in stage III non–small cell lung cancer, which suggests novel patient stratification criteria for therapy sequencing.